Aortic valve stenosis” is an often-overlooked condition and a growing health concern in ageing societies such as Thailand.

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had ...

JenaValve today announced new results from an expanded cohort receiving its Trilogy transcatheter heart valve (THV) system.

MiRus announced that it launched a U.S. multi-center early feasibility study for its Siegel transcatheter heart valve (THV).

Over 100 patients successfully treated with the DurAVR ® THV, including de novo (first time) aortic stenosis cases, valve-in-valve (ViV) patients and complex anatomies such as bicuspid aortic valve ...

A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...

Having a coronary artery calcium (CAC) score of zero has generally been accepted as a marker of a very low risk of having a ...

Aortic stenosis is a condition where the aortic valve narrows, obstructing blood flow from the heart to the aorta. As a ...

With regional differences in which name is used for the aortic fix, some say unity is needed. Others can live with both.

Rising prevalence of cardiovascular diseases and rapid advancements in minimally invasive procedures are fueling the growth ...

Researchers found that a gene on the Y chromosome influences how aortic valve stenosis progresses differently in males and ...